Family Legacy Inc. Has $270,000 Position in Aflac Incorporated (NYSE:AFL)

Family Legacy Inc. increased its position in shares of Aflac Incorporated (NYSE:AFL) by 4.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,607 shares of the financial services provider’s stock after buying an additional 107 shares during the quarter. Family Legacy Inc.’s holdings in Aflac were worth $270,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Aflac in the 4th quarter valued at $349,699,000. Raymond James Financial Inc. acquired a new stake in shares of Aflac during the 4th quarter valued at about $163,409,000. Amundi increased its stake in Aflac by 81.1% in the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock valued at $285,181,000 after acquiring an additional 1,232,683 shares during the period. Vanguard Group Inc. lifted its stake in Aflac by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock worth $5,310,640,000 after purchasing an additional 653,275 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in Aflac by 670.9% during the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock valued at $57,572,000 after purchasing an additional 484,378 shares in the last quarter. 67.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the company’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company’s stock, valued at $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Morgan Stanley raised their target price on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Piper Sandler lowered their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Barclays cut their price objective on Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, February 7th. Finally, JPMorgan Chase & Co. lifted their price target on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $103.36.

Aflac Stock Performance

AFL stock opened at $109.71 on Monday. The business’s fifty day moving average is $106.49 and its 200-day moving average is $107.66. The company has a market cap of $59.88 billion, a P/E ratio of 11.43, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.